Targeted Biological and Cellular Immunotherapies for Osteosarcoma
GM Robbins - 2023 - search.proquest.com
Osteosarcoma (OSA) is the most common cancer of the bone and third most common cancer
diagnosed in children and adolescent. The five-year survival rate for OSA patients …
diagnosed in children and adolescent. The five-year survival rate for OSA patients …
Targeted Biological and Cellular Immunotherapies for Osteosarcoma
G Robbins - 2023 - conservancy.umn.edu
Osteosarcoma (OSA) is the most common cancer of the bone and third most common cancer
diagnosed in children and adolescent. The five-year survival rate for OSA patients …
diagnosed in children and adolescent. The five-year survival rate for OSA patients …